BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Turnstone Biologics Corp. Reports Second Quarter 2023 Financial Results and Provides Business Update

  Turnstone Biologics Corp. announced financial results for the second quarter ended June 30, 2023, and provided an update on recent business highlights.

  September 1, 2023

   · 

  8 min read
• Medivir Hosts Expert Perspectives Webcast on the Evolving Treatment Landscape and the Unique Treatment Challenges in HCC

  Medivir AB announced that it will host a key opinion leader webcast on the current and future HCC treatment landscape, including how treatment challenges and needs in HCC differs from most other cancers.

  September 1, 2023

   · 

  4 min read
• BioMidwest

  Exact Sciences to participate in September 2023 investor conference

  Exact Sciences Corp. announced that company management will participate in the following conference and invited investors to participate by webcast.

  September 1, 2023

   · 

  1 min read
• Bio NC

  United Therapeutics Corporation to Present at the Morgan Stanley 21st Annual Global Healthcare Conference

  United Therapeutics Corporation announced that James Edgemond, Chief Financial Officer and Treasurer, will provide an overview and update on the company’s business during a fireside chat session at the Morgan Stanley 21st Annual Global Healthcare Conference in New York City.

  September 1, 2023

   · 

  2 min read
• Elastin Biosciences Announces Breakthrough Discovery in Elastin Restoration: Paving the Way for Treatment of Elastin-Deficiency Diseases

  Longaevus Technologies, announces the spin-off of Elastin Biosciences following breakthrough preclinical results of 3 of its assets.

  September 1, 2023

   · 

  2 min read
• Genetown

  Repligen Corporation to Present at Wells Fargo Healthcare Conference

  Repligen Corporation, a life sciences company focused on bioprocessing technology leadership, announced that it will be presenting at the Wells Fargo Healthcare Conference being held September 6 -8 in Boston.

  September 1, 2023

   · 

  1 min read
• Drug Development

  Genentech’s Alecensa Delivers Unprecedented Phase III Results for People With ALK-Positive Early-Stage Lung Cancer

  Genentech, a member of the Roche Group, announced that the Phase III ALINA study evaluating Alecensa®, compared with platinum-based chemotherapy, met its primary endpoint of disease-free survival at a prespecified interim analysis.

  September 1, 2023

   · 

  9 min read
• Business

  Leslie McDonnell joins Mölnlycke’s Board of Directors

  Leslie McDonnell has more than 20 years of experience in the Medtech industry through executive leadership roles at Medtronic, 3M Healthcare, and Natus Medical.

  September 1, 2023

   · 

  1 min read
• Business

  Dr. Hitto Kaufmann appointed Chief Scientific Officer of Hansa Biopharma

  Hansa Biopharma, “Hansa”, a pioneer in enzyme technology for rare immunological conditions, announced that Dr. Hitto Kaufmann has been appointed as Hansa’s Chief Scientific Officer effective 1 December 2023.

  September 1, 2023

   · 

  4 min read
• Hugel resubmits BLA for its botulinum toxin, Letybo to the U.S. FDA

  Hugel, a global total medical aesthetics company, announced that the company resubmitted the BLA for its botulinum toxin, Letybo (letibotulinumtoxinA) on August 31st (local time), for the indication of glabellar (frown) lines to the U.S. FDA.

  September 1, 2023

   · 

  1 min read